Molecular mechanism of dioxolane nucleosides against 3TC resistant M184V mutant HIV

Antiviral Research

Volumn 63, Issue 1, 2004, Pages 7-13

  Chong, Youhoon ^a   Chu, Chung K ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

3TC resistance; Dioxolane; HIV; Molecular modeling; Nucleoside

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFICACY; ENERGY TRANSFER; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANTI-HIV AGENTS; BINDING SITES; DIOXOLANES; DRUG RESISTANCE, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; LAMIVUDINE; METHIONINE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; VALINE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2942594279     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.01.004     Document Type: Article

References (28)

1. Bennett L.L., Parker W.B., Allan P.W., Rose L.M., Shealy Y.F., Secrist J.A. III, Montgomery J.A., Arnett G., Kirkman R.L., Shannon W.M. Phosphorylation of the enantiomers of the carbocyclic analog of 2′-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase. Mol. Pharmacol. 44:1993;1258-1266
2. Blaney J.M., Weiner P.K., Dearing A., Kollman P.A., Jorgensen E.C., Oatley S.J., Burridge J.M., Blake C.C.F. Molecular mechanics simulation of protein-ligand interactions: binding of thyroid hormone analogs to prealbumin. J. Am. Chem. Soc. 104:1982;6424-6434
3. Chong Y., Chu C.K. Understanding the unique mechanism of L-FMAU (Clevudine) against hepatitis B virus: molecular dynamics studies. Bioorg. Med. Chem. Lett. 12:2002;3459-3462
4. Chong Y., Borroto-Esoda K., Furman P.A., Schinazi R.F., Chu C.K. Molecular mechanism of DAPD/DXG against zidovudine- and lamivudine-drug resistant mutants: a molecular modelling approach. Antivir. Chem. Chemother. 13:2002a;115-128
5. Chong Y., Choo H., Choi Y., Matthew J., Schinazi R.F., Chu C.K. Stereoselective synthesis and antiviral activity of D-2′, 3′-didehydro-2′, 3′-dideoxy-2′-fluoro-4′- thionucleosides. J. Med. Chem. 45:2002b;4888-4898
6. Chong, Y., Schinazi, R.F., Chu, C.K., 2003. Abstr. 10th CROI, abstr. 611.
7. Coates J.A.V., Cammack N., Jenkinson H.J., Mutton I.M., Pearson B.A., Storer R., Cameron J.M., Penn C.R. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 36:1992;202-205
8. Cornell W.D., Cieplak P., Bayly C.I., Gould I.R., Merz K.M. Jr., Ferguson D.M., Spellmeyer D.C., Fox T., Caldwell J.W., Kollman P.A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:1995;5179-5197
9. Dunitz J.D., Taylor R. Organic fluorine hardly ever accepts hydrogen bonds. Chem. Eur. J. 3:1997;89-98
10. Focher F., Maga G., Bendiscioli A., Capobianco M., Colonna F., Garbesi A., Spadari S. Stereospecificity of human DNA-polymerases-α, -β, -γ, -δ and -ε, HIV-reverse transcriptase, HSV-1 DNA-polymerase, calf thymus terminal transferase and Escherichia coli DNA-polymerase 1 in recognizing D- and L-thymidine 5′-triphosphate as substrate. Nucleic Acids Res. 23:1995;2840-2847
11. Fu L., Liu S.-H., Cheng Y.-C. Sensitivity of L-(-)2′, 3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues. Biochem. Pharmacol. 57:1999;1351-1359
12. Furman P.A., Davis M., Liotta D.C., Paff M., Frick L.W., Nelson D.J., Dornsife R.E., Wurster J.A., Wilson L.J., Fyfe J.A., Tuttle J.V., Miller W.H., Condreay L., Averett D.R., Schinazi R.F., Painter G.R. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1, 3-oxathiolan-5-yl] cytosine. Antimicrob. Agents Chemother. 36:1992;2686-2692
13. Furman P.A., Jeffrey J., Keifer L.L., Feng J.Y., Anderson J.S., Borroto-Esoda K., Hill E., Copeland W.C., Chu C.K., Sommadossi J.P., Liberman I., Schinazi R.F., Painter G.R. Mechanism of action of 1-β-D-2, 6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-β-D-dioxolane guanosine. Antimicrob. Agents Chemother. 45:2001;158-165
14. Furman P.A., Wilson J.E., Reardon J.E., Painter G.R. The effect of absolute configuration on the anti-HIV and anti-HBV activity of nucleoside analogues. Antivir. Chem. Chemother. 6:1995;345-355
15. Gästeiger J., Marsili M. Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron. 36:1980;3219-3228
16. Gu Z., Wainberg M.A., Nguyen-Ba N., L'Heureux L., De Muys J.M., Bowlin T.L., Rando R.F. Mechanism of action and in vitro activity of 1′, 3′-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. Antimicrob. Agents Chemother. 43:1999;2376-2382
17. Huang H., Chopra R., Verdine G.L., Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science. 282:1998;1669-1675
18. Kavlick M.F., Shirasaka T., Kojima E., Pluda J.M., Hui F. Jr., Yarchoan R., Mitsuya H. Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (-)-2′, 3′-dideoxy-3′-thiacytidine. Antivir. Res. 28:1995;133-146
19. Kim H.O., Ahn S.K., Alves A.J., Beach J.W., Jeong L.S., Choi B.G., Van Roey P., Schinazi R.F., Chu C.K. Asymmetric synthesis of 1, 3-dioxolane pyrimidine nucleosides and their anti-HIV activity. J. Med. Chem. 35:1992;1987-1995
20. Larder B.A., Kemp S.D., Harrigan P.R. Potential mechanisim for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science. 269:1995;696-699
21. Lee K., Chu C.K. Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents. Antimicrob. Agents Chemother. 45:2001;138-144
22. Purcell W.P., Singer J.A. A brief review and table of semiempirical parameters used in the Hückel molecular orbital method. J. Chem. Eng. Data. 12:1967;235-246
23. Spadari S., Ciarrocchi G., Focher F., Verri A., Maga G., Arcamone F., Iafrate E., Manzini S., Garbesi A., Tondelli L. 5-Iodo-2′-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2′-deoxy-L-uridine: selective phosphorylation by herpes-simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies. Mol. Pharmacol. 47:1995;1231-1238
24. Tisdale M., Kemp S.D., Parry N.R., Larder B.A. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5653-5656
25. Van Draanen N.A., Tucker S.C., Boyd F.L., Trotter B.W., Reardon J.E. β-L-Thymidine 5′-triphosphate analogs as DNA polymerase substrates. J. Biol. Chem. 267:1992;25019-25024
26. Weiner S.J., Kollman P.A., Nguyen D.T., Case D.A. An all atom force-field for simulations of proteins and nucleic-acids. J. Comp. Chem. 7:1986;230-252
27. Wipff G., Dearing A., Weiner P.K., Blaney J.M., Kollman P.A. Molecular mechanics studies of enzyme-substrate interactions: the interaction of L- and D-N-acetyltryptophanamide with α-chymotrypsin. J. Am. Chem. Soc. 105:1983;997-1005
28. Yamaguchi T., Iwanami N., Shudo K., Saneyoshi M. Chiral discrimination of enantiomeric 2′-deoxythymidine 5′-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases. Synthetic nucleosides and nucleotides. Biochem. Biophys. Res. Commun. 200:1994;1023-1027